Bioventus (BVS) Goodwill & Intangibles (2020 - 2026)
Bioventus (BVS) posted Goodwill & Intangibles of $367.1 million for Q1 2026, down 2.33% on a QoQ basis from $375.9 million in Q4 2025, and down 8.95% year-over-year from $403.2 million in Q1 2025.
Bioventus (BVS) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Bioventus' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $367.1 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 8.95% year-over-year to $367.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $367.1 million (down 8.95% YoY) and the FY2025 annual result came in at $375.9 million, down 8.81% from the prior year.
- Goodwill & Intangibles was $367.1 million for Q1 2026 at Bioventus, down from $375.9 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $1.1 billion in Q4 2022 and bottomed at $367.1 million in Q1 2026.
- A 5-year average of $532.6 million and a median of $478.1 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles surged 255.0% — and 2023, when it plunged 53.24%.
- Bioventus' Goodwill & Intangibles stood at $647.3 million in 2022, then decreased by 24.33% to $489.8 million in 2023, then declined by 15.85% to $412.2 million in 2024, then dropped by 8.81% to $375.9 million in 2025, then dropped by 2.33% to $367.1 million in 2026.
- Business Quant data shows BVS's Goodwill & Intangibles at $367.1 million in Q1 2026, $375.9 million in Q4 2025, and $384.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Bioventus | 826.74 Mn | 790.89 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 367.12 Mn |
| Dec 31, 2025 | 375.88 Mn |
| Sep 27, 2025 | 384.86 Mn |
| Jun 28, 2025 | 394.42 Mn |
| Mar 29, 2025 | 403.19 Mn |
| Dec 31, 2024 | 412.19 Mn |
| Sep 28, 2024 | 422.27 Mn |
| Jun 29, 2024 | 432.01 Mn |
| Mar 30, 2024 | 478.13 Mn |
| Dec 31, 2023 | 489.81 Mn |
| Sep 30, 2023 | 500.79 Mn |
| Jul 1, 2023 | 512.69 Mn |
| Apr 1, 2023 | 523.50 Mn |
| Dec 31, 2022 | 647.31 Mn |
| Oct 1, 2022 | 1.07 Bn |
| Jul 2, 2022 | 809.68 Mn |
| Apr 2, 2022 | 829.34 Mn |
| Dec 31, 2021 | 842.82 Mn |
| Oct 2, 2021 | 301.68 Mn |
| Jul 3, 2021 | 309.98 Mn |